HomepageEarnings Events Newsdesk 4 hours ago ANI Pharmaceuticals, Inc (ANIP) ANI Pharmaceuticals Announces the FDA Approval and Launch of Pimozide Tablets with 180 Day CGT Exclusivity ANI Pharmaceuticals, Inc (NASDAQ: ANIP) FY 2026 Other Release AECOM (ACM) Q2 2026 Earnings Announcement » « Merck & Co., Inc. (MRK) FDA Grants Priority Review for KEYTRUDA® (pembrolizumab) and KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa-pmph), Each with Padcev® (enfortumab vedotin-ejfv), for Cisplatin-Eligible Patients with Muscle-Invasive Bladder Cancer Newsdesk:
